Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
Richards, Duncan B, Cookson, Louise M, Berges, Alienor C, Barton, Sharon V, Lane, Thirusha, Ritter, James M, Fontana, Marianna, Moon, James C, Pinzani, Massimo, Gillmore, Julian D, Hawkins, Philip N, Pepys, Mark B
Published in The New England journal of medicine (17.09.2015)
Published in The New England journal of medicine (17.09.2015)
Get full text
Journal Article
QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small-Molecule New Drug Applications Approved During 2011-2019
Cohen-Rabbie, Sarit, Berges, Alienor C, Rekić, Dinko, Parkinson, Joanna, Dota, Corina, Tomkinson, Helen K
Published in Journal of clinical pharmacology (01.08.2021)
Published in Journal of clinical pharmacology (01.08.2021)
Get more information
Journal Article
Dose-Dependent Progressive Immunotherapeutic Clearance of Systemic Amyloid Deposits By Repeated Doses of Antibody to Serum Amyloid P Component (SAP)
Pepys, Mark B, Cookson, Louise M, Barton, Sharon V, Berges, Alienor C, Lane, Thirusha, Hutt, David, Fontana, Marianna, Moon, James C, Gillmore, Julian D, Wechalekar, Ashutosh, Hawkins, Philip N, Richards, Duncan B
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN FOR USE IN TREATING POLYANGIITIS, HYPEREOSINOPHILIC SYNDROME, HYPEREOSINOPHILIC SYNDROME CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP), OR CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS (CRSSNP)
BIRD, Nicholas P, MONCK, Myrna A, AUSTIN, Daren J, ZECCHIN, Chiara, POULIQUEN, Isabelle J, SHUMAN, Melissa A, BERGES, Alienor C
Year of Publication 09.10.2024
Get full text
Year of Publication 09.10.2024
Patent
INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN FOR USE IN TREATING POLYANGIITIS, HYPEREOSINOPHILIC SYNDROME, HYPEREOSINOPHILIC SYNDROME CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP), OR CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS (CRSSNP)
BIRD, Nicholas P, MONCK, Myrna A, AUSTIN, Daren J, ZECCHIN, Chiara, POULIQUEN, Isabelle J, SHUMAN, Melissa A, BERGES, Alienor C
Year of Publication 08.06.2023
Get full text
Year of Publication 08.06.2023
Patent
INTERLEUKIN 5 BINDING PROTEIN DOSAGE REGIMEN FOR USE IN TREATING POLYANGIITIS, HYPEREOSINOPHILIC SYNDROME, HYPEREOSINOPHILIC SYNDROME CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP), OR CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS (CRSSNP
ZECCHIN, CHIARA, BIRD, NICHOLAS P, SHUMAN, MELISSA A, BERGES, ALIENOR C, POULIQUEN, ISABELLE J, MONCK, MYRNA A, AUSTIN, DAREN J
Year of Publication 08.06.2023
Get full text
Year of Publication 08.06.2023
Patent
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease
Grove, Richard A, Harrington, Conn M, Mahler, Andreas, Beresford, Isabel, Maruff, Paul, Lowy, Martin T, Nicholls, Andrew P, Boardley, Rebecca L, Berges, Alienor C, Nathan, Pradeep J, Horrigan, Joseph P
Published in Current Alzheimer research (01.01.2014)
Get more information
Published in Current Alzheimer research (01.01.2014)
Journal Article